Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antje Rottmann

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|October 29, 2025
Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy VolunteersKlaus Francke, Antje Rottmann, Stefan Klein, et al.
Investigative Radiology|June 11, 2025
Pharmacokinetics, Excretion, and Organ Distribution of the Novel Gadolinium-Based MRI Contrast Agent Gadoquatrane in Female Cynomolgus MonkeysClemens Guenther, Thomas Frenzel, Antje Rottmann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2003
Solution- and bound-state conformational study of N,N',N"-triacetyl chitotriose and other analogous potential inhibitors of hevamine: application of trNOESY and STD NMR spectroscopyAntje Germer, Clemens Mügge, Martin G Peter, et al.
Analytical Biochemistry|July 8, 2008
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetateMatthias Koitka, Joachim Höchel, Detlev Obst, et al.
Clinical Pharmacokinetics|September 27, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive OverviewMarcus-Hillert Schultze-Mosgau, Bart A Ploeger, Matthias Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
The starch-related R1 protein is an alpha -glucan, water dikinaseGerhard Ritte, James R Lloyd, Nora Eckermann, et al.
Investigative Radiology|November 3, 2023
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy AdultsBirte Maria Hofmann, Kai Riecke, Stefan Klein, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 5, 2022
Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist EliapixantKlaus Francke, Niladri Chattopadhyay, Stefan Klein, et al.
Clinical Pharmacokinetics|January 14, 2018
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug-Drug Interaction PotentialMarcus-Hillert Schultze-Mosgau, Joachim Höchel, Olaf Prien, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidateMarkus Berger, Ekkehard May, Hartmut Rehwinkel, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|October 29, 2025
Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy VolunteersKlaus Francke, Antje Rottmann, Stefan Klein, et al.
Investigative Radiology|June 11, 2025
Pharmacokinetics, Excretion, and Organ Distribution of the Novel Gadolinium-Based MRI Contrast Agent Gadoquatrane in Female Cynomolgus MonkeysClemens Guenther, Thomas Frenzel, Antje Rottmann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2003
Solution- and bound-state conformational study of N,N',N"-triacetyl chitotriose and other analogous potential inhibitors of hevamine: application of trNOESY and STD NMR spectroscopyAntje Germer, Clemens Mügge, Martin G Peter, et al.
Analytical Biochemistry|July 8, 2008
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetateMatthias Koitka, Joachim Höchel, Detlev Obst, et al.
Clinical Pharmacokinetics|September 27, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive OverviewMarcus-Hillert Schultze-Mosgau, Bart A Ploeger, Matthias Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
The starch-related R1 protein is an alpha -glucan, water dikinaseGerhard Ritte, James R Lloyd, Nora Eckermann, et al.
Investigative Radiology|November 3, 2023
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy AdultsBirte Maria Hofmann, Kai Riecke, Stefan Klein, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 5, 2022
Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist EliapixantKlaus Francke, Niladri Chattopadhyay, Stefan Klein, et al.
Clinical Pharmacokinetics|January 14, 2018
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug-Drug Interaction PotentialMarcus-Hillert Schultze-Mosgau, Joachim Höchel, Olaf Prien, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidateMarkus Berger, Ekkehard May, Hartmut Rehwinkel, et al.
Pageof 3